Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Clinical Trials in New York

758 recruiting clinical trials across 15 cities in New York (NY). Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
758
Total Trials
758
Recruiting Now
15
Cities
20
Conditions

Recruiting Trials in New York

Clinical trial data sourced from ClinicalTrials.gov. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT00567073

Pompe Pregnancy Sub-Registry

This Sub-registry is a multicenter, international, longitudinal, observational, and voluntary program designed to track pregnancy outcomes for any pregnant woman enrolled in the...

Sponsor: Genzyme, a Sanofi CompanyEnrolling: 2020 locations
Glycogen Storage Disease Type II (GSD-II)Pompe Disease (Late-onset)Glycogenesis 2 Acid Maltase Deficiency
RECRUITINGNCT00682695

Genetic and Environmental Risk Factors for Hemorrhagic Stroke

The purpose of this study is to find risk factors for hemorrhagic stroke.

Sponsor: State University of New York at BuffaloEnrolling: 10007 locations
Stroke
RECRUITINGNCT01109368

The Rogosin Institute Homozygous Familial Hypercholesterolemia Repository

This repository will establish for the first time a system to carefully assess and monitor over time the general health and the amount of cholesterol in the arteries of U.S....

Sponsor: The Rogosin InstituteEnrolling: 601 location
Homozygous Familial Hypercholesterolemia
RECRUITINGNCT01209000

Nephrotic Syndrome Study Network

Minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), and Membranous nephropathy (MN), generate an enormous individual and societal financial burden, accounting...

Sponsor: University of MichiganEnrolling: 120020 locations
Minimal Change Disease (MCD)Membranous NephropathyGlomerulosclerosis, Focal Segmental
RECRUITINGNCT01241305

One-Time DNA Study for Vasculitis

The purpose of this study is to identify genes that increase the risk of developing vasculitis, a group of severe diseases that feature inflammation of blood vessels. Results of...

Sponsor: University of PennsylvaniaEnrolling: 100014 locations
Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss)Giant Cell ArteritisGranulomatosis With Polyangiitis (Wegener's)+3
RECRUITINGPhase 1 / Phase 2NCT01269853

Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA

The high-grade malignant brain tumors, glioblastoma multiforme (GBM) and anaplastic astrocytoma (AA), comprise the majority of all primary brain tumors in adults. This group of...

Sponsor: Northwell HealthEnrolling: 541 location
Glioblastoma MultiformeAnaplastic Astrocytoma
RECRUITINGNCT01353547

Genes and Environment in Multiple Sclerosis

The purpose of the research study is to identify the genetic, environmental and immune profiles that may increase a person's risk of developing multiple sclerosis (MS). While MS...

Sponsor: Columbia UniversityEnrolling: 50005 locations
Multiple Sclerosis
RECRUITINGNCT01656447

Scleroderma Registry & Repository at the Hospital for Special Surgery

The overall objective of the Scleroderma Registry is to support and promote the basic science and clinical research of this complex rheumatic disease at the Hospital for Special...

Sponsor: Hospital for Special Surgery, New YorkEnrolling: 3001 location
Scleroderma
RECRUITINGPhase 1 / Phase 2NCT01659203

Proton or Photon RT for Retroperitoneal Sarcomas

This research study is a Phase I clinical trial. Phase I clinical trials test the safety of an investigational intervention. Phase I studies also try to define the appropriate...

Sponsor: Massachusetts General HospitalEnrolling: 8010 locations
Retroperitoneal Sarcoma
RECRUITINGNCT01694940

North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)

The North American Mitochondrial Disease Consortium (NAMDC) maintains a patient contact registry and tissue biorepository for patients with mitochondrial disorders.

Sponsor: Columbia UniversityEnrolling: 100017 locations
Mitochondrial DisordersMitochondrial Genetic DisordersMitochondrial Diseases+2
RECRUITINGNCT01776398

Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies

The purpose of this study is to obtain biologic materials from the blood, airways and/or urine of normal individuals and individuals with lung disease. The normal are used to...

Sponsor: Weill Medical College of Cornell UniversityEnrolling: 20001 location
Chronic Obstructive Pulmonary Disease (COPD)SmokingSmoking Cessation+3
RECRUITINGNCT01802034

Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)

A central goal of this data repository is to collect data from a large population of subjects with a variety of renal disease states. Cohorts will include subjects with diabetes,...

Sponsor: The Rogosin InstituteEnrolling: 20001 location
Kidney DiseasesKidney Failure, ChronicDiabetic Nephropathy+2
RECRUITINGPhase 3NCT01804686

A Long-term Extension Study of PCI-32765 (Ibrutinib)

The purpose of this study is to collect long-term safety and efficacy data for participants treated with ibrutinib and to provide ongoing access to ibrutinib for participants who...

Sponsor: Janssen Research & Development, LLCEnrolling: 70020 locations
Chronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaMantle Cell Lymphoma+4
RECRUITINGNCT01860339

Child to Adult Neurodevelopment in Gene Expanded Huntington's Disease

Huntington's Disease (HD) is an autosomal dominant disease manifested in a triad of cognitive, psychiatric, and motor signs and symptoms. HD is caused by a triplet repeat...

Sponsor: Peggy C NopoulosEnrolling: 4006 locations
Huntington's Disease
RECRUITINGPhase 1 / Phase 2NCT01906385

Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)

This is a multi-center, sequential cohort, open-label, volume and dose escalation study of the safety, tolerability, and distribution of 186RNL given by convection enhanced...

Sponsor: Plus TherapeuticsEnrolling: 553 locations
Glioma
RECRUITINGNCT01915511

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

The Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry started recruiting in 2014 with the objective of studying Idiopathic Pulmonary Fibrosis. In 2018, the...

Sponsor: Duke UniversityEnrolling: 300020 locations
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
RECRUITINGPhase 3NCT02000089

The Cancer of the Pancreas Screening-5 CAPS5)Study

Johns Hopkins clinical research office quality assurance group will monitor and audit this study at Johns Hopkins. The Sub Investigator at each site will be responsible for...

Sponsor: Johns Hopkins UniversityEnrolling: 90009 locations
Pancreas CancerPeutz-Jeghers Syndrome (PJS)Gene Mutation+2
RECRUITINGPhase 1 / Phase 2NCT02140255

Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission

The study will explore the effects of early intensive antiretroviral therapy (ART) with or without a broadly neutralizing antibody (bNAb) on achieving HIV remission (HIV RNA below...

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)Enrolling: 112020 locations
HIV Infection
RECRUITINGPhase 1 / Phase 2NCT02332668

A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma...

Researchers are looking for new ways to treat children with different types of melanoma (skin cancer), solid tumors, and lymphomas (blood cancers) that are any of these: *...

Sponsor: Merck Sharp & Dohme LLCEnrolling: 37017 locations
MelanomaLymphomaSolid Tumor+2
RECRUITINGPhase 1 / Phase 2NCT02343042

Selinexor and Backbone Treatments of Multiple Myeloma Patients

This study will independently assess the efficacy and safety of 11 combination therapies in 12 arms, in dose-escalation/-evaluation and expansion phases, for the treatment of...

Sponsor: Karyopharm Therapeutics INCEnrolling: 30020 locations
Multiple Myeloma
RECRUITINGNCT02432560

Safety and Durability of Sirolimus for Treatment of LAM

The MIDAS study aims to follow male and female LAM patients who are currently taking, have previously failed or been intolerant of, or may (at some time in the future) take mTOR...

Sponsor: University of CincinnatiEnrolling: 60020 locations
Lymphangioleiomyomatosis
RECRUITINGPhase 2NCT02675959

Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease

This is a follow-up trial to NYMC 526 (NCT01461837) to assess the safety, efficacy and toxicity of administering Defibrotide prophylaxis for high-risk sickle cell or beta...

Sponsor: New York Medical CollegeEnrolling: 404 locations
Sickle Cell Disease
RECRUITINGPhase 3NCT02735707

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

REMAP-CAP is a randomised, embedded, multifactorial, adaptive platform trial for community-acquired pneumonia. The purpose of this study is to evaluate the effect of a range of...

Sponsor: UMC UtrechtEnrolling: 2000020 locations
Community-acquired Pneumonia, Influenza, COVID-19
RECRUITINGNCT02773082

DBS for Obsessive-Compulsive Disorder

There are two primary approaches to the treatment of OCD, pharmacotherapy and cognitive behavior therapy (CBT). Lack of therapeutic success with one approach leads to trials of...

Sponsor: Northwell HealthEnrolling: 501 location
Obsessive-Compulsive Disorder (OCD)
RECRUITINGNCT02775461

Pancreas Registry and High Risk Registry

The purpose of this study is to establish a registry of patients with pancreatic diseases. Patients included in the registry may include those with: pancreatic cancer,...

Sponsor: Icahn School of Medicine at Mount SinaiEnrolling: 13682 locations
Pancreas CancerPancreatitisChronic Pancreatitis+3
RECRUITINGNCT02777879

Lung Microbiome and Inflammation in Early COPD

This is a cross sectional case controlled study to assess lung microbiome and inflammation in smokers with and without Chronic Obstructive Pulmonary Disease (COPD). Investigators...

Sponsor: NYU Langone HealthEnrolling: 2301 location
Chronic Obstuctive Pulmonary Disease
RECRUITINGNCT02779478

Evaluation Of The Lung Microbiome In NTM Bronchiectasis

A biomarker cohort study design is proposed to study whether specific airway microbiota alterations are associated with pulmonary Non-tuberculous mycobacteria (NTM) disease. In a...

Sponsor: NYU Langone HealthEnrolling: 10001 location
Nontuberculous MycobacteriaBronchiectasis
RECRUITINGNCT02780297

Prospective Research Rare Kidney Stones (ProRKS)

The purpose of this study is to determine the natural history of the hereditary forms of nephrolithiasis and chronic kidney disease (CKD), primary hyperoxaluria (PH), cystinuria,...

Sponsor: Mayo ClinicEnrolling: 22011 locations
HyperoxaluriaCystinuriaDent Disease+2
RECRUITINGPhase 2NCT02800486

Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of...

Primary brain tumors are typically treated by surgery, radiation therapy and chemotherapy, either individually or in combination. Present therapies are inadequate, as evidenced by...

Sponsor: Northwell HealthEnrolling: 371 location
GlioblastomaAnaplastic AstrocytomaAnaplastic Oligoastrocytoma+6
RECRUITINGNCT02897908

Non-invasive Liver Screening Using FibroScan Device for Liver Disease Patients for the Steatosis/Fibrosis Database

The primary goal of this study is to establish a database of people with varying levels of hepatic fibrosis and various etiologies of liver disease for use in future research...

Sponsor: State University of New York at BuffaloEnrolling: 10001 location
Disease of Liver and Bile Duct

Showing 30 of 758 trials in New York. Search all trials

Browse Trials by State

Frequently Asked Questions

There are currently 758 clinical trials actively recruiting participants in New York. These span all phases from early-stage Phase 1 to late-stage Phase 3 trials, across 20+ conditions.

The top conditions with recruiting trials in New York include Multiple Myeloma, Ovarian Cancer, Sickle Cell Disease, Colorectal Cancer, Prostate Cancer. Each has multiple active trials across research centers in the state.

Major trial sites in New York include New York, The Bronx, Rochester, Buffalo, Commack. Most large academic medical centers and research hospitals serve as trial sites.

Review the trial listings on this page and check the eligibility criteria — we translate them into plain English. When you find a trial that fits, talk to your doctor about whether it's right for you, then contact the trial team directly using the information on the trial page.

Sources: ClinicalTrials.gov
Last updated:

Trial data sourced from the ClinicalTrials.gov API. Location data reflects registered trial sites. This site does not provide medical advice.